These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 10095971

  • 1. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
    Paiva LC, Pinto-Neto AM, Faundes A.
    Contraception; 1998 Dec; 58(6):351-5. PubMed ID: 10095971
    [Abstract] [Full Text] [Related]

  • 2. Long-term depot-medroxyprogesterone acetate and bone mineral density.
    Tang OS, Tang G, Yip P, Li B, Fan S.
    Contraception; 1999 Jan; 59(1):25-9. PubMed ID: 10342083
    [Abstract] [Full Text] [Related]

  • 3. Bone density in long term users of depot medroxyprogesterone acetate.
    Gbolade B, Ellis S, Murby B, Randall S, Kirkman R.
    Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
    [Abstract] [Full Text] [Related]

  • 4. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
    Orr-Walker BJ, Evans MC, Ames RW, Clearwater JM, Cundy T, Reid IR.
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):615-8. PubMed ID: 10197077
    [Abstract] [Full Text] [Related]

  • 5. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR.
    BMJ; 1991 Jul 06; 303(6793):13-6. PubMed ID: 1830502
    [Abstract] [Full Text] [Related]

  • 6. Forearm bone density in users of Depo-Provera as a contraceptive method.
    Bahamondes L, Perrotti M, Castro S, Faúndes D, Petta C, Bedone A.
    Fertil Steril; 1999 May 06; 71(5):849-52. PubMed ID: 10231044
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
    Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K.
    Contraception; 1997 Jul 06; 56(1):1-3. PubMed ID: 9306024
    [Abstract] [Full Text] [Related]

  • 8. Trabecular bone in long-term depot-medroxyprogesterone acetate users.
    Virutamasen P, Wangsuphachart S, Reinprayoon D, Kriengsinyot R, Leepipatpaiboon S, Gua C.
    Asia Oceania J Obstet Gynaecol; 1994 Sep 06; 20(3):269-74. PubMed ID: 7811192
    [Abstract] [Full Text] [Related]

  • 9. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z.
    J Pediatr; 1996 Nov 06; 129(5):671-6. PubMed ID: 8917232
    [Abstract] [Full Text] [Related]

  • 10. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.
    Wanichsetakul P, Kamudhamas A, Watanaruangkovit P, Siripakarn Y, Visutakul P.
    Contraception; 2002 Jun 06; 65(6):407-10. PubMed ID: 12127638
    [Abstract] [Full Text] [Related]

  • 11. Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women.
    Zhang MH, Zhang W, Zhang AD, Yang Y, Gai L.
    Chin Med J (Engl); 2013 Nov 06; 126(21):4043-7. PubMed ID: 24229671
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
    Piya-Anant M, Koetsawang S, Patrasupapong N, Dinchuen P, d'Arcangues C, Piaggio G, Pinol A.
    Contraception; 1998 Jan 06; 57(1):23-8. PubMed ID: 9554247
    [Abstract] [Full Text] [Related]

  • 13. Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate. A cross-sectional study of Thai women.
    Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K.
    Contraception; 1997 Sep 06; 56(3):153-5. PubMed ID: 9347205
    [Abstract] [Full Text] [Related]

  • 14. [Status of bone mineral density after the long-standing application of contraception Depo-Provera].
    Zeman S, Havlík P, Zemanová J, Němec D.
    Ceska Gynekol; 2013 Jan 06; 78(1):116-24. PubMed ID: 23607391
    [Abstract] [Full Text] [Related]

  • 15. Changes in calcium metabolism and bone mineral density in new users of medroxyprogesterone acetate during the first year of use.
    Quintino-Moro A, Zantut-Wittmann DE, Silva Dos Santos PN, Silva CA, Bahamondes L, Fernandes A.
    Int J Gynaecol Obstet; 2019 Dec 06; 147(3):319-325. PubMed ID: 31479152
    [Abstract] [Full Text] [Related]

  • 16. Weight change in adolescents who used hormonal contraception.
    Risser WL, Gefter LR, Barratt MS, Risser JM.
    J Adolesc Health; 1999 Jun 06; 24(6):433-6. PubMed ID: 10401972
    [Abstract] [Full Text] [Related]

  • 17. A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.
    Cundy T, Ames R, Horne A, Clearwater J, Roberts H, Gamble G, Reid IR.
    J Clin Endocrinol Metab; 2003 Jan 06; 88(1):78-81. PubMed ID: 12519833
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral density in women using depot medroxyprogesterone acetate for contraception.
    Scholes D, Lacroix AZ, Ott SM, Ichikawa LE, Barlow WE.
    Obstet Gynecol; 1999 Feb 06; 93(2):233-8. PubMed ID: 9932562
    [Abstract] [Full Text] [Related]

  • 19. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus.
    Petta CA, Faundes A, Dunson TR, Ramos M, DeLucio M, Faundes D, Bahamondes L.
    Fertil Steril; 1998 Feb 06; 69(2):252-7. PubMed ID: 9496338
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.